Head-to-head · Cost-Efficiency Index
Trava Health vs Renlo Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Trava Health
Shoppers who verify the actual quoted price and their state's eligibility directly at checkout before trusting the homepage banner.
Visit Trava HealthRenlo Health
Someone who wants a flat monthly bill that will not step up, with a refund route if it does not work.
Visit Renlo HealthThe verdict
Trava Health and Renlo Health tie on the Cost-Efficiency Index at 78/100, so neither wins outright on the numbers. For most shoppers we'd start with Trava Health (ranked #39, a hair above #42) — Shoppers who verify the actual quoted price and their state's eligibility directly at checkout before trusting the homepage banner. But Renlo Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Trava Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Trava Health | Renlo Health |
|---|---|---|
| Cost-Efficiency Index | 78/100 | 78/100 |
| Semaglutide / mo | $88/mo (starting dose, compounded) | $199/mo, billed monthly at every dose |
| Tirzepatide / mo | $178/mo (starting dose, compounded) | $269/mo, billed monthly at every dose |
| Semaglutide / yr (modeled) | $1,056 | $2,388 |
| Tirzepatide / yr (modeled) | $2,136 | $3,228 |
| Coverage | All 50 states | Not disclosed |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #39 | #42 |
Trava Health
78/100Where the value is
- Transparent quarterly-package discount is disclosed in dollar terms, not just a vague percentage
- HSA/FSA eligible
- Named legal entity and Houston, TX address disclosed in the Terms of Service
The tradeoffs
- Homepage 'As low as' price for semaglutide was NOT stable across repeated reads today ($88.65 vs $117.96) — this is a live, in-session finding, not a hypothetical risk
- Trava's own Terms of Service states the service is 'currently only available to individuals who are located in Texas,' contradicting nationwide/50-state marketing claims elsewhere on the site — unresolved contradiction
Renlo Health
78/100Where the value is
- The headline is the real month-to-month rate — no prepay division and no commitment behind an asterisk
- Names the prescribing physician, Dr. Sean Arora, MD, and the dispensing pharmacy, VialsRX
- Same price at every dose with a price-lock badge, so titrating up never moves the bill
The tradeoffs
- A struck-through $299 sits beside the price with no published basis — Renlo never says what it was, when it applied or to whom
- That strikethrough comes from a stylesheet rule rather than a struck-out element, so a markup-level check would report the page clean
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.